Since their discovery antimicrobial drugs have dramatically reduced the danger of infectious diseases. However the emergence of resistant strains of microbes has now greatly reduced the effectiveness of these drugs. Resistant strains are responsible for regular headline news, from E.Coli outbreaks to the H1N1 pandemic and cost global health services ever increasing amounts of money. The recent ECDC/EMEA Technical Report - The bacterial challenge: time to react has highlighted the urgent need for development of new antimicrobial drugs. "Industry's pipeline contains very few new antibiotics active against multidrug-resistant bacteria. Without stimulating research and development into new antibiotics, an increasing number of infected patients will be without effective treatment". Bo Aronsson, EMEA. "A future without effective antibiotics will exacerbate a situation where already at least 25,000 patients in the EU each year die from infections due to multidrug-resistant bacteria. Patients suffering from healthcare-associated infections will be particularly hard hit" Dominique Monnet, ECDC SMi's 12th Annual Conference will bring you up to date with new and emerging products in the antimicrobials market, with a particular focus on antibacterials and antifungals and allow you to learn from and network with some of the leading individuals and organisations in this ever important area.

 

Key topics include: A global update on emerging antibiotic resistant pathogens  Developments in the emerging global challenge of bacterial multi-drug resistance  Tackling resistance in gram-negative bacteria  Forming strategic alliances with large pharma to develop new antibacterials  New approaches to fungal and protozoal infections   Insights into novel therapies for overcoming resistance

Why should you attend this event?

 

Feedback from our previous events includes: "Excellent range of topics from discovery to development and regulatory challenges." Senior Representative, NovaBay Pharmaceuticals "This was well organised!" Senior Representative, ViroPharma Ltd "Very well organised. Some excellent topics" Senior Representative, IPSAT Therapies "Very informative" Senior Representative, Plant Bioscience

By attending this event you will be able to: Meet the leading figures in antimicrobial development Learn more about novel strategies and solutions for overcoming resistance Increase your knowledge through informative and thought provoking presentations Transfer knowledge with fellow senior executives Engage with potential new clients and suppliers

Hear keynote addresses from:

Professor Peter Hawkey, Professor of Public Health Bacteriology, University of Birmingham & Health Protection Agency

Our expert speaker line-up also includes:

• Dr Jan Alenfall, Chief Executive Officer, DermaGen
• Richard Bax, Senior Partner, TranScrip Partners LLP
• Professor Anthony Coates, Professor of Medical Microbiology, St George's, University of London
• Dr Mike Dawson, Chief Scientific Officer, Novacta
• Dr Graham Dixon, Senior Vice President Drug Discovery, Galapagos NV
• Dr Anders Fugelli, Head of Business Development, Lytix Biopharma
• Dr Jean de Gunzberg, Chief Scientific Officer, Da Volterra
• Dr Jennifer Hannesschlager, Managing Director, Washington DC, McKenna Long & Aldridge LLP
• Dr Katsura Hata, Senior Researcher, Eisai Product Creation Systems
• Dr Nick Housby, Chief Operating Officer & Director, Novolytics
• Dr Alan Johnson, Clinical Scientist, Health Protection Agency
• Dr Laurenz Kellenberger, Chief Scientific Officer, Basilea Pharmaceutica
• Dr Frank Koehn, Director - Biosynthetic and Discovery Analytical Chemistry, Pfizer
• Dr Anil Koul, Head, Department of Anti-Microbial Research, Johnson & Johnson
• Professor Ajit Lalvani, Chair of Infectious Diseases, National Heart and Lung Institute, Imperial College London
• Dr Bill Love, Chief Executive Officer, Destiny Pharma
• Professor Alasdair MacGowan, Professor of Clinical Microbiology & Antimicrobial Therapeutics, University of Bristol/North Bristol NHS Trust 
• Dr Chester A. Metcalf III, Vice President, Discovery Chemistry, Cubist Pharmaceuticals
• Dr John P. Mueller, Senior Director, Biology Lead, Antibacterials Research Unit, Pfizer
• Dr John Northfield, Medical Advisor, Astellas
• Dr Brian Noonan, Director of Bioscience, AstraZeneca
• Dr David Wareham, Clinical Senior Lecturer & Honorary Consultant, Centre for Infectious Disease, Barts and The London School of Medicine and Dentistry 

Who should attend?

All those responsible for research, medical microbiology, antimicrobial therapeutics, clinical development and business development, including:

Chief Scientific Officers Senior Vice Presidents Chief Medical Officers Research Scientists Clinical Microbiologists R&D Project Managers

Heads of Anti-Infectives Discovery Clinical Trials Managers Principal Scientists Senior Vice Presidents of R&D Business Development Managers Product Managers

 Organisations represented at our previous Superbugs and Superdrugs conference include:

Achaogen Affinium Pharmaceuticals Astellas Pharmaceuticals AstraZeneca Bayer Healthcare Cubist Pharmaceuticals Destiny Pharma GlaxoSmithKline Johnson & Johnson Merck Sharp & Dohme NeuTec Pharma Novartis Novexel Novo Nordisk Rib-X Tibotec

Venue details

Crowne Plaza St James London   45-51 Buckingham Gate London   SW1E 6AF   Tel: +44 (0) 207 834 6655 Fax: +44 (0) 207 834 6307   www.london.crowneplaza.com

Crowne Plaza St James London is a traditional deluxe hotel right in the heart of the city, perfectly situated for all your business and leisure needs.  In the heart of Westminster, it is just a stones throw away from Buckingham Palace, The Houses of Parliament, the London Eye and Victoria Station. The hotel boasts three excellent restaurants. Bistro 51 with British and European cuisine, the Michelin Starred Indian restaurant Quilon serving south coastal Indian food and Bank Westminster with a modern British menu.  A beautiful, award-winning, courtyard garden surrounds the Victorian buildings of the Crowne Plaza London St James - a peaceful oasis in the centre of London.   Nearest train stations: • Victoria Station, 7 minutes’ walk • Waterloo Station, 10 minutes by car Underground stations • St James’s Park, 5 minutes’ walk (District and Circle lines) • Victoria Station, 7 minutes' walk (Victoria, District and Circle lines) From St. James's Park Underground Station to the Hotel Take the main St James’s Park exit and turn left into Petty France Street. Continue Straight down for 200 yards and at the end turn left into Buckingham Gate SMi discounted rates include Continental Breakfast & VAT £ 205.63 / Standard room / night for single occupancy £ 229.13 Executive  room / night for single occupancy Book your accommodation at SMi discounted rates by calling us on +44 (0)870 9090 713, sending a fax to +44 (0)870 9090 714 or emailing hotels@smi-online.co.uk.

Conference Documentation

Transcription CD ROM

SMi are pleased to announce our Transcription CD ROM